Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

17.820
-0.370-2.03%
Volume:3.66M
Turnover:66.35M
Market Cap:47.19B
PE:11.98
High:18.500
Open:18.270
Low:17.800
Close:18.190
52wk High:25.915
52wk Low:14.505
Shares:2.65B
HK Float Shares:530.00M
Volume Ratio:2.02
T/O Rate:0.69%
Dividend:0.46
Dividend Rate:2.56%
EPS(LYR):1.487
ROE:6.95%
ROA:1.40%
PB:0.83
PE(LYR):11.98
PS:0.95

Loading ...

Sinopharm Group Stock Sheds 1.2% in Hong Kong

Dow Jones
·
May 21

Sinopharm Group Stock Falls 2.1% in Hong Kong

Dow Jones
·
May 18

FOSUN PHARMA's Strategic Move: $60 Million Secures Potential Over $2.5 Billion for AR1001

Stock News
·
May 14

Fosun Pharma Secures $60 Million Option for Alzheimer's Drug

MT Newswires Live
·
May 14

China's AI Power Consumption Set to Soar, Spotlight on Computing-Power Synergy

Stock News
·
May 14

Fosun Pharma's Unit's Registration Application for Blood Stasis Syndrome Drug Accepted in China

MT Newswires Live
·
May 13

Fosun Pharma Subsidiary’s Tao Hong Si Wu Tang Granules Secures NMPA Filing Acceptance

Bulletin Express
·
May 13

FOSUN PHARMA's Application for Traditional Chinese Medicine New Drug Accepted for Review

Stock News
·
May 13

Shanghai Fosun Pharma - Drug Registration Applications of Tao Hong Si Wu Tang Granules by Unit Accepted by Nmpa China

THOMSON REUTERS
·
May 13

Fosun Pharma Releases 2026 AGM & Second H-Shareholders Meeting Circular; Offers Digital Access and Print Options

Bulletin Express
·
May 11

Fosun Pharma Calls 16 June 2026 H Shareholders Meeting to Seek 10% Dual-Class Buyback Mandates

Bulletin Express
·
May 11

Fosun Pharma Calls 16 June AGM to Vote on RMB0.39 Dividend, RMB35 Billion Guarantee Cap and New Financing Mandates

Bulletin Express
·
May 11

Fosun Pharma's Unit Gets Nod for Registration of Venlafaxine Hydrochloride Tablets

MT Newswires Live
·
May 11

Henlius Biotech Gets European Commission's Nod for Hetronifly

MT Newswires Live
·
May 11

FOSUN PHARMA's Biosimilar HLX05-N Receives FDA Clearance for US Clinical Trial

Stock News
·
May 10

Fosun Pharma Subsidiary Obtains NMPA Green Light for Venlafaxine Sustained-Release Tablets

Bulletin Express
·
May 08

FOSUN PHARMA's Venlafaxine Hydrochloride Extended-Release Tablets Receive Market Approval

Stock News
·
May 08

Shanghai Fosun Pharma - Drug Registration Application for Venlafaxine Hydrochloride Sustained-Release Tablets Approved by China's Nmpa

THOMSON REUTERS
·
May 08

Sinopharm Group Stock Sheds 1.6% in Hong Kong

Dow Jones
·
May 08

Leadership Reshuffle Sweeps Pharmaceutical Sector: Hengrui, Fosun, AstraZeneca, Pfizer Among Key Players

Deep News
·
May 07